07/22/2024
4:59 PM | Processa Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/18/2024
3:42 PM | Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/18/2024
3:46 PM | Processa Pharmaceuticals (Issuer)
SKIBSTED RUSSELL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
1:19 PM | Processa Pharmaceuticals (Filer)
| Form DEFR14A | |
05/28/2024
11:15 PM | Processa Pharmaceuticals (Filer)
| Form EFFECT | |
05/28/2024
3:49 PM | Processa Pharmaceuticals (Filer)
| Form 424B5 | |
|
05/21/2024
3:13 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:57 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:01 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:50 PM | Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:52 PM | Bigora Sian (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
3:55 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/04/2024
11:05 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
4:25 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
3:22 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/01/2024
5:32 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:34 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:37 PM | Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/30/2024
9:46 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2024
11:15 PM | Processa Pharmaceuticals (Filer)
| Form EFFECT | |
01/25/2024
7:35 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
7:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2024
7:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
3:30 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
7:55 AM | Processa Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
12/19/2023
8:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:18 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/16/2023
2:10 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2023
10:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
1:45 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
4:31 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4/A | |
10/16/2023
8:15 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/12/2023
4:56 PM | Processa Pharmaceuticals (Issuer)
Yorke Justin W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:58 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:01 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:04 PM | Ng George K (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
5:07 PM | Guy Wendy (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2023
4:54 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
New trading system called MSFT, NVDA & MSFT (Ad) Look 2023 kind of sucked from a trading standpoint…
Despite the market finishing 24% higher….
Just seven stocks did all of the work…
Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped…
According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today. Just follow this link here! |
10/10/2023
4:00 PM | Lin Patrick (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:03 PM | Processa Pharmaceuticals (Issuer)
Young David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
4:05 PM | Pannu Geraldine (Reporting)
Processa Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
3:51 PM | Processa Pharmaceuticals (Issuer)
Stanker James H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
9:00 AM | Processa Pharmaceuticals (Filer)
| Form DEF 14A | |
10/05/2023
9:01 AM | Processa Pharmaceuticals (Filer)
| Form DEFA14A | |
09/25/2023
3:09 PM | Processa Pharmaceuticals (Filer)
| Form PRE 14A | |
09/21/2023
4:29 PM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
11:00 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
9:30 AM | Processa Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
